Boya Bio-pharmaceutical Group (300294) Stock Overview

China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the blood products, and biochemical and chemical drugs businesses in China and internationally. It offers blood products comprising human fibrinogen, intravenous human immunoglobulin, rabies immunoglobulin, human albumin, and human immunoglobulin; non-blood products, including metformin hydrochloride enteric-coated tablets, pioglitazone hydrochloride dispersible tablets, glipizide tablets, glimepiride tablets, pioglitazone hydrochloride dispersible tablets, simvastatin tablets, and calcium dobesilate capsules. The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co., Ltd. The company was founded in 1993 and is based in Fuzhou, China.